These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 24518077)

  • 21. Tumor control, eye preservation, and visual outcomes of ruthenium plaque brachytherapy for choroidal melanoma.
    Marconi DG; de Castro DG; Rebouças LM; Bernardes Gil GO; Fogaroli RC; Conte Maia MA; Gobo Silva ML; Assis Pellizzon AC; Motono Chojniak MM
    Brachytherapy; 2013; 12(3):235-9. PubMed ID: 22436517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo monosomy 3 detection of posterior uveal melanoma: 3-year follow-up.
    Midena E; Bonaldi L; Parrozzani R; Radin PP; Boccassini B; Vujosevic S
    Graefes Arch Clin Exp Ophthalmol; 2008 Apr; 246(4):609-14. PubMed ID: 17934749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of candidate tumor oncogenes by integrative molecular analysis of choroidal melanoma fine-needle aspiration biopsy specimens.
    McCannel TA; Burgess BL; Rao NP; Nelson SF; Straatsma BR
    Arch Ophthalmol; 2010 Sep; 128(9):1170-7. PubMed ID: 20837802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ruthenium-106 plaque radiotherapy alone or in combination with transpupillary thermotherapy in the management of choroidal melanoma.
    Gündüz K; Kurt RA; Akmeşe HE; Köse K; Uçakhan-Gündüz O
    Jpn J Ophthalmol; 2010 Jul; 54(4):338-43. PubMed ID: 20700803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined brachytherapy and transpupillary thermotherapy for large choroidal melanoma: tumor regression and early complications.
    Kreusel KM; Bechrakis N; Riese J; Krause L; Wachtlin J; Foerster MH
    Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1575-80. PubMed ID: 16738857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [High-dose 106Ruthenium plaque brachytherapy for posterior uveal melanoma. A clinico-pathologic study].
    Heindl LM; Lotter M; Strnad V; Sauer R; Naumann GO; Knorr HL
    Ophthalmologe; 2007 Feb; 104(2):149-57. PubMed ID: 17123048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ruthenium-106 versus iodine-125 plaque brachytherapy of 571 choroidal melanomas with a thickness of ≥5.5 mm.
    Filì M; Trocme E; Bergman L; See TRO; André H; Bartuma K; Girnita L; All-Eriksson C; Seregard S; Stålhammar G
    Br J Ophthalmol; 2020 Jan; 104(1):26-32. PubMed ID: 30910871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endoresection technique with/without brachytherapy for management of high posterior choroidal melanoma: extended follow-up results.
    Garcia-Arumi J; Leila M; Zapata MA; Velázquez D; Dinares-Fernandez MC; Tresserra F; Corcostegui B
    Retina; 2015 Apr; 35(4):628-37. PubMed ID: 25462434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting local control of choroidal melanomas following ¹⁰⁶Ru plaque brachytherapy.
    Papageorgiou KI; Cohen VM; Bunce C; Kinsella M; Hungerford JL
    Br J Ophthalmol; 2011 Feb; 95(2):166-70. PubMed ID: 20889528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling.
    Browne AW; Dandapani SV; Jennelle R; Stevanovic M; Lee TC; Murphree AL; Kampp TD; Astrahan MA; Kim JW; Berry JL
    Brachytherapy; 2015; 14(5):718-25. PubMed ID: 26073224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Risk factors for the recurrence of choroidal melanoma after the Ru-106 brachytherapy].
    Bogdali A; Romanowska-Dixon B
    Klin Oczna; 2015; 117(3):169-72. PubMed ID: 26999940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local tumor control after 106Ru brachytherapy of choroidal melanoma.
    Damato B; Patel I; Campbell IR; Mayles HM; Errington RD
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):385-91. PubMed ID: 15913907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small metastasizing choroidal melanomas.
    Malclès A; Kivelä T; Svetlosakova Z; Jean-Louis B; Nguyen AM; Sallit R; Négrier S; Pommier P; Rivoire M; Chauvel P; Mammar H; Devouassoux-Shisheboran M; Kodjikian L; Denis P; Grange JD
    Acta Ophthalmol; 2015 Mar; 93(2):e160-6. PubMed ID: 25124923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Forecasting the prognosis of choroidal melanoma with an artificial neural network.
    Kaiserman I; Rosner M; Pe'er J
    Ophthalmology; 2005 Sep; 112(9):1608. PubMed ID: 16023213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Predictors of Regression of Choroidal Melanomas after Brachytherapy: A Growth Curve Model.
    Rashid M; Heikkonen J; Singh AD; Kivelä TT
    Ophthalmology; 2018 May; 125(5):747-754. PubMed ID: 29499831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of positive dual-modality positron emission tomography/computed tomography imaging of primary choroidal melanoma with chromosome 3 loss and tumor size.
    McCannel TA; Reddy S; Burgess BL; Auerbach M
    Retina; 2010 Jan; 30(1):146-51. PubMed ID: 20010323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cluster analysis of multiplex ligation-dependent probe amplification data in choroidal melanoma.
    Caines R; Eleuteri A; Kalirai H; Fisher AC; Heimann H; Damato BE; Coupland SE; Taktak AF
    Mol Vis; 2015; 21():1-11. PubMed ID: 25684974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitrectomy and Vitrector Port Needle Biopsy of Choroidal Melanoma for Gene Expression Profile Testing Immediately before Brachytherapy.
    Reddy DM; Mason LB; Mason JO; Crosson JN; Yunker JJ
    Ophthalmology; 2017 Sep; 124(9):1377-1382. PubMed ID: 28461017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromosome 3 intratumor heterogeneity in uveal melanoma.
    Mensink HW; Vaarwater J; Kiliç E; Naus NC; Mooy N; Luyten G; Brüggenwirth HT; Paridaens D; de Klein A
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):500-4. PubMed ID: 18824727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.